Dr. Suneet Nitin Purohit, MD

Dr. Purohit practices at Alaska Heart Institute in Anchorage, Alaska.

Dr. Purohit's NPI, 1760781553, was assigned on March 21, 2011. Dr. Purohit graduated from Boston University School of Medicine in 2011. Dr. Purohit holds Alaska license 142762.

Dr. Purohit's primary practice is Alaska Heart Institute, at 3841 Piper St, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 561-3211.

Dr. Purohit's primary practice is Alaska Heart Institute in Anchorage, Alaska. Dr. Purohit is also affiliated with Providence Alaska Medical Center. The medical group on file is Alaska Heart & Vascular Institute. Dmand AI also links Dr. Purohit to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Purohit practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Purohit's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Purohit's licenses on file in 2 states: Alaska and Washington.

CMS data shows 5,833 Medicare services from Dr. Purohit across 32 procedure codes in 2024, for 1,864 Medicare patients. Medicare paid $277,791 for them.

CMS counts 1,864 Medicare patients who saw Dr. Purohit in 2024. The largest group is 65 to 74, with 809 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Purohit's median patient age at 69, with 43% women.

In 2024, Dr. Purohit wrote 4,900 Medicare Part D claims for 428 patients. 69% of them were for generic drugs. CMS names the drug for 4,645 of them, across 40 drugs with 11 or more claims each, at $4,453,981 in total drug cost. In 2023, CMS named 3,976 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Purohit for performance year 2024, reported as part of a group. Dr. Purohit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Purohit as offering telehealth.

Dmand AI links 6 papers to Dr. Purohit, published from 2019 to 2020. The most frequent topics are Heart Failure, Heart and Heart-Assist Devices. Dr. Purohit has published most often in Circ Heart Fail. Dr. Purohit's most frequent co-authors are Amrut V. Ambardekar, MD, Michelle Angelique Barron, MD and Prateeti Prabhaker Khazanie, MD.

Dmand AI links Dr. Purohit to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pericarditis and Heart Diseases. Open Payments lists research payments to Dr. Purohit that name 1 trial.

CMS Open Payments shows 250 general payments to Dr. Purohit from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Bristol-Myers Squibb Company paid the most, $39,868. It also lists 1 research payment totaling $187 in 2024, naming 1 clinical trial.

Dr. Purohit graduated from Boston University School of Medicine in 2011.